Stay updated on Psilocybin vs Escitalopram for MDD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.

Latest updates to the Psilocybin vs Escitalopram for MDD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record with a standard error page and blocking access to the trial details. This effectively hides core content that users rely on to view the study information.SummaryDifference19%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This is a metadata/version update and does not modify the study content presented on the page.SummaryDifference0.1%

- Check39 days agoChange DetectedA line reading '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, reflecting NIH funding for the trial.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This reflects a minor update to the page's template or metadata rather than substantive content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a newer build of the page.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the site's versioning that does not alter the study information.SummaryDifference0.1%

Stay in the know with updates to Psilocybin vs Escitalopram for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.